Pembrolizumab Plus Y90 Radioembolization in HCC Subjects

Clinical trial NCT03099564 · UNKNOWN

Trial details

NCT number: NCT03099564
Sponsor: Ashwin Somasundaram
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2017-03-28
Primary completion: 2021-05-19
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.